EXPRESS SCRIPTS HLDG CO (ESRX) Stock News
NASDAQ:ESRX - Nasdaq - US30219G1085
ESRX Latest News, Press Relases and Analysis
Eli Lilly’s New Weight-Loss Drug Now on Sale to Rival Hard-to-Find Wegovy
Eli Lilly & Co.’s new weight-loss drug Zepbound is now available at US pharmacies, offering an alternative to rival medications like Novo Nordisk A/S’s Wegovy as supply issues persist.
Mentions: LLY
ElectroCore inks rebate agreement with Ascent Health Services; shares up 6% premarket
ElectroCore (NASDAQ:ECOR) announces that Ascent Health Services on behalf of Express Scripts (NASDAQ:ESRX), has elected to make gammaCore a preferred brand on all of its Standard National Formularies
Mentions: ECOR
TNN | Stock Watch: Express Scripts Holding Company (NASDAQ: ESRX)
Margin of Safety Calculated for NASDAQ:ESRX | Healthcare, News
TNN | Stock Valuation: Express Scripts Holding Company (NASDAQ: ESRX)
Margin of Safety Calculated for NASDAQ:ESRX | Healthcare, News
TNN | Latest Movement: Express Scripts Holding Company (NASDAQ: ESRX)
Margin of Safety Calculated for NASDAQ:ESRX | Healthcare, News
TNN | Trading Results: Express Scripts Holding Company (NASDAQ: ESRX)
Margin of Safety Calculated for NASDAQ:ESRX | Healthcare, News
Express Scripts Simplifies Digital Health Technology Marketplace for Consumers and Payers
Accredo, a Full-Service Specialty Pharmacy, Expands Best-in-Class Services with New Pharmacy in Hawaii
Biotech Bonanza: 2019 Outlook
In 2019 biotech stocks will have an uphill battle, but will still provide opportunities for attractive gains.
Stocks making the biggest moves premarket: WBA, BB, MO, ACN & more
Some of the names on the move ahead of the open.
3 Cheap Stocks to Buy Before They Skyrocket
Low valuations and strong growth make these cheap stocks attractive buys. Here's what investors need to know about each stock.
Merck Slips After Announcing Acquisition of France's Antelliq Group
Merck buys French digital animal identification solutions company Antelliq Group.
Walmart and Express Scripts Sign Three-Year Agreement to Deliver Greater Value to Insured and Uninsured Pharmacy Customers
Mentions: WMT
Expect Less M&A in 2019 as Big Year Comes to a Close
It was a big year for mergers and acquisitions, as predicted. What now? The trend can't last forever.
Tired of Stock Market Volatility? It’s Been a Good Year to Bet on Mergers.
It’s been a choppy year for investors, with the stock market enduring some violent swings. One type of fund, however, has been relatively unscathed by 2018’s turmoil
Apple scoops up CEO of Mango Health, a start-up that helps people keep track of their medications
Apple's health team makes another high-profile hire: Jason Oberfest, the longtime CEO of Mango Health.
George Soros Bought These 2 Healthcare Stocks in the Third Quarter
The Soros Fund Management bought shares of both Express Scripts and Zai Lab Limited during the third quarter.
Express Scripts' Miller says Washington at incredible moment on drug pricing
This week the Trump administration proposed allowing Medicare Part D pharmacy drug plans to be more selective on branded drugs from what are known as the six special therapeutic classes, which include cancer treatments and H-I-V antiviral drugs.
Amazon's PillPack may be gearing up to serve the e-retailer's employees before broader rollout
Amazon's PillPack has filed for a few new licenses, including to ship from Phoenix to Washington, which may point to a plan to serve the company's employees first.
Analysts Offer Insights on Services Companies: Old Dominion Freight (NASDAQ: ODFL) and Express Scripts (NASDAQ: ESRX)
Companies in the Services sector have received a lot of coverage today as analysts weigh in on Old Dominion Freight (ODFL – Research Report) and Express Scripts (ESRX – Research Report). Old Dominion Freight (ODFL) In a report released yesterday, Allison Landry from Credit Suisse maintained a Buy rating on Old Dominion Freight, with a
Mentions: ODFL
Express Scripts (ESRX) Gets a Hold Rating from Oppenheimer
In a report released today, Mohan Naidu from Oppenheimer maintained a Hold rating on Express Scripts (ESRX – Research Report). The company’s shares opened today at $96.48, close to its 52-week high of $100.43. Naidu wrote: “We increased our 2019 claims growth in the core business to 2%, up from our prior estimate of 5%
Walmart, Home Depot adopt health insurer tactic in drug copay battle
Walmart and Home Depot , two of the top 10 U.S. employers, have embraced a healt...
Walmart, Home Depot adopt a health insurer tactic in their drug copay battle
Walmart and Home Depot have embraced a health insurance strategy that punishes drugmakers for using discount cards to keep patients from switching or stopping their medications.
Express Scripts Introduces Novel Formulary Built for Evolution of Drug Pricing
5 Stocks to Sell After the Midterm Election
Trump and House Democrats look poised to make deals that will hurt these stocks to sell. Here's what investors need to know.
3 Cheap Stocks to Buy Before They Skyrocket
Low valuations and strong growth make these cheap stocks attractive buys. Here's what investors need to know about each stock.
Express Scripts' myMatrixx Launches myDataSense Analytics Tool
CVS Health Earnings Due; These Top Stocks Report: Investing Action Plan
CVS Health earnings are due Tuesday, as are earnings from Eli Lilly, Jazz Pharmaceuticals, Match Group. Etsy, Ralph Lauren and some shale companies.
Express Scripts (ESRX) Receives a Buy from Cowen & Co.
In a report issued on October 31, Charles Rhyee from Cowen & Co. maintained a Buy rating on Express Scripts (NASDAQ: ESRX), with a price target of $88. The company’s shares closed yesterday at $96.74, close to its 52-week high of $98.98. According to TipRanks.com, Rhyee is a 4-star analyst with an average return of
Cigna Stock Clears Buy Point On Strong Earnings; Molina Beats
Cigna earnings topped views, with Cigna stock clearing a buy point. Fellow health insurer Molina Healthcare also beat views. Molina stock soared.
Cigna Stock Clears Buy Point On Strong Earnings; Molina Jumps
Cigna earnings topped views, with Cigna stock clearing a buy point. Fellow health insurer Molina Healthcare also beat views. Molina stock soared.